These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 16176541

  • 1. Electrophysiologic effects of carvedilol: is carvedilol an antiarrhythmic agent?
    El-Sherif N, Turitto G.
    Pacing Clin Electrophysiol; 2005 Sep; 28(9):985-90. PubMed ID: 16176541
    [Abstract] [Full Text] [Related]

  • 2. Carvedilol: molecular and cellular basis for its multifaceted therapeutic potential.
    Cheng J, Kamiya K, Kodama I.
    Cardiovasc Drug Rev; 2001 Sep; 19(2):152-71. PubMed ID: 11484068
    [Abstract] [Full Text] [Related]

  • 3. Myocardial protection by the novel vasodilating beta-blocker, carvedilol: potential relevance of anti-oxidant activity.
    Feuerstein GZ, Yue TL, Cheng HY, Ruffolo RR.
    J Hypertens Suppl; 1993 Jun; 11(4):S41-8. PubMed ID: 8104241
    [Abstract] [Full Text] [Related]

  • 4. Differential effects of the β-adrenoceptor blockers carvedilol and metoprolol on SQT1- and SQT2-mutant channels.
    Bodi I, Franke G, Pantulu ND, Wu K, Perez-Feliz S, Bode C, Zehender M, zur Hausen A, Brunner M, Odening KE.
    J Cardiovasc Electrophysiol; 2013 Oct; 24(10):1163-71. PubMed ID: 23718892
    [Abstract] [Full Text] [Related]

  • 5. Protective effects of carvedilol in the myocardium.
    Feuerstein GZ, Bril A, Ruffolo RR.
    Am J Cardiol; 1997 Dec 04; 80(11A):41L-45L. PubMed ID: 9412541
    [Abstract] [Full Text] [Related]

  • 6. Effects of carvedilol on left ventricular function and arrhythmias during repeated short-time myocardial ischemia in experimental pigs.
    Höher M, Friedrich M, Sommer T, Marten A, Ehmer B, Hombach V, Hirche H.
    Z Kardiol; 1989 Dec 04; 78 Suppl 3():7-15. PubMed ID: 2573214
    [Abstract] [Full Text] [Related]

  • 7. Carvedilol's antiarrhythmic properties: therapeutic implications in patients with left ventricular dysfunction.
    Naccarelli GV, Lukas MA.
    Clin Cardiol; 2005 Apr 04; 28(4):165-73. PubMed ID: 15869048
    [Abstract] [Full Text] [Related]

  • 8. Carvedilol and its new analogs suppress arrhythmogenic store overload-induced Ca2+ release.
    Zhou Q, Xiao J, Jiang D, Wang R, Vembaiyan K, Wang A, Smith CD, Xie C, Chen W, Zhang J, Tian X, Jones PP, Zhong X, Guo A, Chen H, Zhang L, Zhu W, Yang D, Li X, Chen J, Gillis AM, Duff HJ, Cheng H, Feldman AM, Song LS, Fill M, Back TG, Chen SR.
    Nat Med; 2011 Jul 10; 17(8):1003-9. PubMed ID: 21743453
    [Abstract] [Full Text] [Related]

  • 9. Carvedilol: beta-blockade and beyond.
    Stroe AF, Gheorghiade M.
    Rev Cardiovasc Med; 2004 Jul 10; 5 Suppl 1():S18-27. PubMed ID: 15184840
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Carvedilol, a novel vasodilating beta-blocker with the potential for cardiovascular organ protection.
    Feuerstein GZ, Ruffolo RR.
    Eur Heart J; 1996 Apr 10; 17 Suppl B():24-9. PubMed ID: 8733068
    [Abstract] [Full Text] [Related]

  • 12. Alpha and beta adrenoceptor blocking action of carvedilol in the canine mesenteric artery and vein.
    Seki N, Nagao T, Komori K, Suzuki H.
    J Pharmacol Exp Ther; 1988 Sep 10; 246(3):1116-22. PubMed ID: 2901485
    [Abstract] [Full Text] [Related]

  • 13. Beta-blockers as antiarrhythmic agents.
    Zicha S, Tsuji Y, Shiroshita-Takeshita A, Nattel S.
    Handb Exp Pharmacol; 2006 Sep 10; (171):235-66. PubMed ID: 16610347
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Carvedilol: something else than a simple betablocker?
    Palazzuoli A, Calabria P, Verzuri MS, Auteri A.
    Eur Rev Med Pharmacol Sci; 2002 Sep 10; 6(6):115-26. PubMed ID: 12776805
    [Abstract] [Full Text] [Related]

  • 18. The beta-adrenergic blocker carvedilol restores L-type calcium current in a myocardial infarction model of rabbit.
    Li X, Huang CX, Jiang H, Cao F, Wang T.
    Chin Med J (Engl); 2005 Mar 05; 118(5):377-82. PubMed ID: 15780206
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Carvedilol-mediated antioxidant protection against doxorubicin-induced cardiac mitochondrial toxicity.
    Oliveira PJ, Bjork JA, Santos MS, Leino RL, Froberg MK, Moreno AJ, Wallace KB.
    Toxicol Appl Pharmacol; 2004 Oct 15; 200(2):159-68. PubMed ID: 15476868
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.